Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
摘要:
In this work, we further investigated a previously introduced class of cholinesterase inhibitors. The removal of the carbarnic function from the lead compound xanthostigmine led to a reversible cholinesterase inhibitors 3. Some new 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-one analogs were designed, synthesized, and evaluated for their inhibitory activity against both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The length of the alkoxy chain of compound 3 was increased and different substituents were introduced. From the IC50 values, it clearly appears that the carbamic residue is crucial to obtain highly potent AChE inhibitors. On the other hand, peculiarity of these compounds is the high selectivity toward BuChE with respect to AChE, being compound 12 the most selective one (6000-fold). The development of selective BuChE inhibitors may be of great interest to clarify the physiological role of this enzyme and to provide novel therapeutics for various diseases. (c) 2006 Elsevier Ltd. All rights reserved.
Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[ω-(benzylmethylamino)alkoxy]xanthen-9-ones
摘要:
In this work, we further investigated a previously introduced class of cholinesterase inhibitors. The removal of the carbarnic function from the lead compound xanthostigmine led to a reversible cholinesterase inhibitors 3. Some new 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-one analogs were designed, synthesized, and evaluated for their inhibitory activity against both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The length of the alkoxy chain of compound 3 was increased and different substituents were introduced. From the IC50 values, it clearly appears that the carbamic residue is crucial to obtain highly potent AChE inhibitors. On the other hand, peculiarity of these compounds is the high selectivity toward BuChE with respect to AChE, being compound 12 the most selective one (6000-fold). The development of selective BuChE inhibitors may be of great interest to clarify the physiological role of this enzyme and to provide novel therapeutics for various diseases. (c) 2006 Elsevier Ltd. All rights reserved.
4-(MeO)3C6H2C(H)=NR (R = CH2CH2OH, 1; R = Me, 17; R = Et, 18; R = Pr, 19; R = tBu, 20) with palladium(II) acetate in toluene gave the dinuclear cyclometallated complexes [Pd2,3,4-(MeO)3C6HC(H)=NR}(μ-O2CMe)]2 (R = CH2CH2OH, 2; R = Me, 21; R = Et, 22; R = Pr, 23; R = tBu, 24), with the ligand bonded to the palladium atom through the imine nitrogen and the C6 carbon atoms. The 1H and 13C1H} NMRspectra of the
席夫碱配体的处理 2,3,4-(MeO)3C6H2C(H)=NR (R = CH2CH2OH, 1; R = Me, 17; R = Et, 18; R = Pr, 19; R = tBu, 20) 在甲苯中用乙酸钯 (II) 得到双核环金属化配合物 [Pd2,3,4-(MeO)3C6HC(H)=NR}(μ-O2CMe)]2 (R = CH2CH2OH, 2; R = Me, 21; R = Et, 22; R = Pr, 23; R = tBu, 24),配体通过亚胺氮和 C6 碳原子与钯原子键合。配合物的 1H 和 13C1H} NMR 谱表明溶液中存在反异构体和顺异构体。anti/syn 比率随溶剂和亚胺氮取代基 R 的性质而变化。具有大体积 tBu 基团的配合物 24 在氯仿中显示出 28:1 的比率,而体积较小的取代配合物显示出较低的比率。描述了配合物 2 顺式异构体的 X 射线晶体结构。乙酰基桥连络合物